Seminar articles
The association between obesity and the progression of prostate and renal cell carcinoma

https://doi.org/10.1016/j.urolonc.2004.10.004Get rights and content

Abstract

Obesity has been linked to the incidence and mortality of several malignancies, including prostate and renal cancer. Increased body mass appears to have a more consistent association with prostate cancer mortality than incidence and recent studies suggest that it may be related to higher recurrence rates after radical prostatectomy. Obesity has an even stronger association with the development and progression of renal cancer, particularly in women. Since obesity is one of few modifiable risk factors that may impact the clinical course of these cancers, lifestyle and dietary changes to limit obesity should be recommended.

Introduction

Obesity has become a major health problem in this country, affecting over 30% of the adult population [1]. In the recently published National Health and Nutrition Examination Survey (NHANES) which obtained measured height and weight data from a nationally representative sample of over 4000 U.S. adults, the age-adjusted prevalence of obesity had increased from 22.9% in the 1988–1994 survey to 30.5% in the more current 1999–2000 survey [1]. This trend was seen in all age and ethnic groups. The incidence of severe or “morbid” obesity had nearly tripled over this time, from 0.78% in 1990 to 2.2% in 2000, with rates as high as 6% in black women and 3.4% in persons who had not completed high school [2]. Even more concerning is that childhood obesity has also increased dramatically with an estimated current prevalence of 15% in children aged 6–19 years [3]. Obesity is associated with many chronic medical problems including diabetes, hypertension, heart disease, stroke and hypercholesterolemia, and it was estimated that health care costs attributable to obesity in this country amounted to $99 billion per year in 1995, and currently accounts for up to 7% of the total health care budget [4], [5]. Americans spend about $30 billion per year on weight reduction programs, most of which are unsuccessful [6]. The importance of obesity as a national epidemic in this country cannot be overstated.

In addition to its association with the development of several chronic medical conditions, obesity has also been linked to several types of cancer [7], [8]. Animal studies have consistently shown that animals forced to decrease energy intake have lower cancer incidences than animals allowed to eat as much as they want [9]. A recent large prospective cohort investigation confirms multiple previous studies suggesting an association between obesity and cancer development in humans [10]. This study monitored more than 900,000 U.S. adults who were free of cancer at enrollment in 1982, over a 16-year period of follow-up, and the relationship between body mass index (BMI) and death from cancer was assessed for various cancer types. The heaviest members of this cohort (BMI > 40 kg/m2) had 52% and 62% higher cancer death rates for men and women respectively, compared to those of normal weight. In both men and women, BMI was also associated with higher rates of death due to cancer of the esophagus, colon and rectum, liver, gallbladder, pancreas, and kidney. Significant trends were also noted for cancer of the stomach and prostate in men, and cancers of the breast, uterus, cervix, and ovaries in women. It was estimated that the current overweight and obesity patterns in this country could alone account for 14% of all deaths from cancer in men and 20% of those in women [10]. While the biologic mechanisms linking obesity to cancer risk are not yet clear, this and other studies suggest that body mass may indeed play an important role in the initiation and progression of some malignancies.

Section snippets

Obesity and prostate cancer

The epidemiologic evidence linking obesity to the risk of developing prostate cancer has been inconclusive. Although several large epidemiological studies have found a positive relationship between prostate cancer incidence and increased BMI, a similar number of studies show no association, and some show a protective effect [11], [12], [13], [14], [15], [16], [17], [18], [19], [20], [21], [22], [23], [24], [25], [26], [27]. A large cohort study of 135,000 Swedish construction workers followed

Outcome after radical prostatectomy

To explore the hypothesis that obesity predicts more aggressive disease in clinically localized prostate cancer, two recent studies investigate the possibility that obesity is related to higher recurrence rates after radical prostatectomy (RP) [28], [29]. Both studies were retrospective analyses of multi-institutional series and examined the relationship between BMI and the risk of prostate-specific antigen (PSA) recurrence in large multiethnic populations. In both studies, obesity resulted in

Potential biologic explanations

The biologic processes underlying the association between prostate cancer progression and obesity are unknown, although several potential mechanisms have been proposed [30]. Since prostate cancer is a hormonally dependent malignancy, hormonal alterations associated with obesity may have some role. Although obesity is generally associated with higher estrogen and lower testosterone levels, which on the surface might seem protective, it also results in lower levels of sex hormone-binding globulin

Obesity and kidney cancer

While much less common than prostate cancer, the risk of kidney or renal cell cancer (RCC) also appears to be related to obesity. A direct relationship between obesity and kidney cancer risk, especially in women, has been consistently noted in past studies. In one of the first published case-control studies investigating this relationship, 495 cases and 697 controls from the Minneapolis-St. Paul, Minnesota region were analyzed [47]. A higher BMI was found to be a major risk factor for women,

Potential mechanisms

Several potential and interrelated mechanisms may be responsible for the increased risk of RCC with obesity [65]. Some of the biologic processes proposed for prostate cancer may also have a role in kidney cancer. Although IGF-1 has not been found to have as strong an association to RCC as prostate cancer, some studies suggest a possible relationship, and insulin and leptin levels may also have a role [66], [67], [68]. Obesity may increase the risk of RCC in women by increasing blood levels of

Conclusions

While epidemiologic studies report conflicting results on the relationship between obesity and prostate cancer risk, several imply that obesity may be more closely related to prostate cancer death. Thus, obesity may be one of many risk factors that are responsible for the promotion of latent prostate cancer to a more significant form of disease. Several potential biologic mechanisms have been proposed to explain why obesity might result in more aggressive disease, including alterations in

References (86)

  • K.M. Flegal et al.

    Prevalence and trends in obesity among US adults, 1999–2000

    JAMA

    (2002)
  • D.S. Freedman et al.

    Trends and correlates of class 3 obesity in the United States from 1990 through 2000

    JAMA

    (2002)
  • C.L. Ogden et al.

    Prevalence and trends in overweight among US children and adolescents. 1999–2000

    JAMA

    (2002)
  • A.M. Wolf et al.

    Current estimates of the economic cost of obesity in the United States

    Obes Res

    (1998)
  • D. Thompson et al.

    The medical-care cost burden of obesity

    Obes Rev

    (2001)
  • M. Mitka

    Economist takes aim at “big fat” US lifestyle

    JAMA

    (2003)
  • K.K. Carroll

    Obesity as a risk factor for certain types of cancer

    Lipids

    (1998)
  • H. Adami et al.

    Obesity and mortality from cancer

    N Engl J Med

    (2003)
  • P. Mukherjee et al.

    Energy intake and prostate tumor growth, angiogenesis, and vascular endothelial growth factor expression

    J Natl Cancer Inst

    (1999)
  • E.E. Calle et al.

    Overweight, obesity and mortality from cancer in a prospectively studied cohort of U.S. adults

    N Engl J Med

    (2003)
  • S.O. Andersson et al.

    Body size and prostate cancera 20-year follow-up study among 135,006 Swedish construction workers

    J Natl Cancer Inst

    (1997)
  • A.G. Schuurman et al.

    Anthropometry in relation to prostate cancer risk in the Netherlands Cohort Study

    Am J Epidemiol

    (2000)
  • E. Giovannucci et al.

    Body mass index and risk of prostate cancer in U.S. health professionals

    J Natl Cancer Inst

    (2003)
  • D.A. Snowdon et al.

    Diet, obesity, and risk of fatal prostate cancer

    Am J Epidemiol

    (1984)
  • C. Rodriguez et al.

    Body mass index, height, and prostate cancer mortality in two large cohorts of adult men in the United States

    Cancer Epidemiol Biomarkers Prev

    (2001)
  • N.M. Aziz et al.

    Weight and prostate cancer in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Trial

    ASCO.

    (2000)
  • R.K. Severson et al.

    Body mass and prostatic cancera prospective study

    BMJ

    (1989)
  • S.D. Putman et al.

    Lifestyle and anthropometric risk factors for prostate cancer in a cohort of Iowa men

    Ann Epidemiol

    (2000)
  • M.B. Veierod et al.

    Dietary fat intake and risk of prostate cancera prospective study of 25,708 Norwegian men

    Int J Cancer

    (1997)
  • A.S. Whittmore et al.

    Prostate cancer in relation to diet, physical activity, and body size in blacks, whites, and Asians in the United States and Canada

    J Natl Cancer Inst

    (1995)
  • A.W. Hsing et al.

    Body size and prostate cancera population-based case-control study in China

    Cancer Epidemiol Biomarkers Prev

    (2000)
  • I.M. Lee et al.

    A prospective cohort study of physical activity and body size in relation to prostate cancer risk (United States)

    Cancer Causes Control

    (2001)
  • T.I. Nilsen et al.

    Anthropometry and prostate cancer riska prospective study of 22,248 Norwegian men

    Cancer Causes Control

    (1999)
  • A. Engeland et al.

    Height, body mass index, and prostate cancera follow-up of 950,000 Norwegian men

    Br J Cancer

    (2003)
  • Y. Furuya et al.

    Smoking and obesity in relation to the etiology and disease progression of prostate cancer in Japan

    Int J Urol

    (1998)
  • C.L. Amling et al.

    Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy

    J Clin Oncol

    (2004)
  • S.J. Freedland et al.

    Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancera report by the Shared Equal Access Regional Cancer Hospital database study group

    J Clin Oncol

    (2004)
  • J.H. Mydlo et al.

    The role of obesity and diet in urological carcinogenesis

    BJU International

    (1999)
  • A.R. Shuldiner et al.

    Resitin, obesity and insulin resistance—the emerging role of the adipocyte as an endocrine organ

    N Engl J Med

    (2001)
  • E. Giovannucci et al.

    Diabetes mellitus and risk of prostate cancer

    Cancer Causes Control

    (1998)
  • J.C. Will et al.

    Is diabetes mellitus associate with prostate cancer incidence and survival?

    Epidemiology

    (1999)
  • A.W. Hsing et al.

    Insulin resistance and prostate cancer risk

    J Natl Cancer Inst

    (2003)
  • H. Yu et al.

    Role of insulin-like growth factor family in cancer development and progression

    J Natl Cancer Inst

    (2000)
  • Cited by (0)

    View full text